Entero Therapeutics
(NASDAQ) FWBI
Entero Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$138.77K
Net Income (TTM)
$19.50M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
FWBI News
FWBI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Entero Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
2
CEO
Jason D. Sawyer
Website
www.enterothera.comHeadquarters
Boca Raton, FL 33431, US
FWBI Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-38%
Net Income Margin
-163%
Return on Equity
-25%
Return on Capital
-4%
Return on Assets
-12%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-3.68%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$15.62M
EBITDA
$15.62M
Operating Cash Flow
$9.22M
Capital Expenditure
$0.00
Free Cash Flow
$9.22M
Cash & ST Invst.
$163.48K
Total Debt
$140.53K
Entero Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
9
N/A
Net Income
$1.15M
+55.3%
EBITDA
$934.79K
+50.6%
Quarterly Fundamentals
Net Cash
$1.68M
+711.9%
Accounts Receivable
$37.49K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$835.61K
+951.7%
Return on Assets
-11.56%
N/A
Return on Invested Capital
-3.53%
N/A
Free Cash Flow
$855.69K
+37.1%
Operating Cash Flow
$855.69K
+54.0%